Walsingham Growth Partners

Walsingham focuses on expansion-stage, late-stage growth, and recapitalization investments in mid-market companies, primarily across North America. The firm targets sectors including enterprise software, fintech, healthcare services, and industrial technology. Its mandate includes minority growth equity, structured recapitalizations, and selective control transactions.

Yes. While headquartered in Toronto, Walsingham's investment mandate covers North America broadly. The firm targets mid-market companies in both Canada and the United States, consistent with a strategy that seeks to bridge the Canada-US private equity corridor for founder-led businesses.

The firm has not publicly disclosed a fixed cheque-size range, but its focus on mid-market expansion and recapitalization deals typically implies equity investments in companies with annual revenue between $10 million and $100 million. Exact target equity amounts remain undisclosed.

The precise legal structure is not public. Based on its strategy as a private equity firm targeting growth equity and recapitalizations, Walsingham likely operates through committed capital vehicles or a pledge-fund model. No fund closes have been publicly reported.

The identities of the founding partners and current investment committee members have not been publicly disclosed in primary sources. The firm operates without a public-facing website or detailed leadership profiles, consistent with a deliberately low-profile boutique posture.